• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Probo Medical Completes Acquisition of National Ultrasound

Share:

May 15, 2023

Probo Medical, a global provider of medical imaging equipment, parts, repair, and service, has acquired National Ultrasound, Inc., a prominent ultrasound marketing and sales organization. The terms of the transaction were not disclosed. National, founded in 2003, has established itself as a leading provider of ultrasound sales and support to veterinary practices. Probo plans to leverage National’s expertise in sales and marketing to expand its ultrasound services. Probo Medical is supported by Avista Capital Partners, a New York-based private equity firm focused on healthcare businesses.

Probo Medical (“Probo”), a leading global provider of medical imaging equipment, parts, repair and service, announced the acquisition of National Ultrasound, Inc. (“National”). Terms of the transaction were not disclosed.

National was founded in 2003 in Duluth, GA and has grown to be one of the largest ultrasound marketing and sales organizations in the country. National has been recognized in the Inc. 5000 list of fastest growing companies for seven consecutive years. Their team brings over 250 years of combined experience working with major ultrasound OEM’s. Over recent years, National has established themselves as a premier provider of ultrasound sales and support to veterinary practices across the country.

“National has a deep history for their sales and marketing prowess, selling new and pre-owned ultrasound equipment to private practices across the country,” said Michael Asmer, CEO of Probo. “They have leveraged that position to expand into the veterinary market. The opportunity to connect this expertise to our world-class ultrasound sales, service, and repair services is tremendously exciting.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“National has been a business built on relationships: with our employees, customers and OEM partners. We found the same values in Probo as we were looking for a partner that could support, and even accelerate, our growth. The depth, breadth and value proposition of Probo’s offering in ultrasound is second to none and we are excited to share that with our customers,” said Joe Williams, CEO of National.

Probo Medical is backed by Avista Capital Partners, a leading New York-based private equity firm with more than 40 growth-oriented healthcare businesses globally.

Source: BioSpace

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Digital Diagnostics Scores $75M to Advance AI-Backed Diagnostic TechDigital Diagnostics Scores $75M to Advance AI-Backed Diagnostic Tech
  • AI Integration Strategies Require Patient Focus, Partnerships.AI Integration Strategies Require Patient Focus, Partnerships.
  • Cedar Nabs $102M to Modernize Patient Financial Experience
  • Oncology Pharma and Ribera Solutions Signed a Licensing Agreement for the Use of Ribera’s Clinical Trials Platform, Connect2MedOncology Pharma and Ribera Solutions Signed a Licensing Agreement for the Use of Ribera’s Clinical Trials Platform, Connect2Med
  • BrightStar Care Continues Nationwide Expansion with Franchise Owner’s Acquisition of Harmony Home CareBrightStar Care Continues Nationwide Expansion with Franchise Owner’s Acquisition of Harmony Home Care
  • Bausch Health Agrees to Sell Amoun PharmaceuticalsBausch Health Agrees to Sell Amoun Pharmaceuticals
  • EQRx Signs $1.8bn Merger Deal with CM Life Sciences IIIEQRx Signs $1.8bn Merger Deal with CM Life Sciences III
  • Litmus Health Releases Next-Gen Clinical Research PlatformLitmus Health Releases Next-Gen Clinical Research Platform

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications